CCCC   $4.25  5.99% Market Closed After Close 4.033 -5.11%

C4 Therapeutics Inc
Total Cash 255.64M
totalCashPerShare 3.622
EBITDA -115.13M
Total Debt 67.09M
quickRatio 6.144
currentRatio 6.311
Total Revenue 33.67M
debtToEquity 27.65
Revenue/Share 0.522
ROA -0.20607
ROE -0.46
grossProfits
freeCashflow -41.84M
operatingCashflow -71.23M
earningsGrowth
revenueGrowth 0.387
grossMargins -2.2230902
ebitdaMargins 0.0
operatingMargins -1.83856
profitMargins 0.0
enterpriseValue 241.34M
forwardPE -3.2802196
floatShares 47.35M
sharesOutstanding 70.59M
sharesShort 6.65M
sharesShortPriorMonth 11.92M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.87%
Short Ratio help_outline 7.48%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 3.439
Price To Book help_outline 1.74
earningsQuarterlyGrowth
netIncomeToCommon -105.50M
trailingEps -1.71%
forwardEps -1.82%
enterpriseToEbitda -2.10
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.43 4Q 2024
institutionsCount 154
lastUpdated Nov. 7, 2024, 3:26 a.m.